The Traderszone Network

Published in TZ Latest News 15 March, 2017 by The TZ Newswire Staff

Merck Blood Cancer Drug Keytruda Wins FDA Nod

Merck’s blockbuster drug Keytruda secured its sixth approval in the US to treat Hodgkin’s lymphoma.